Centene Corp (CNC)vsNomura Holdings Inc ADR (NMR)
CNC
Centene Corp
$62.33
-0.59%
HEALTHCARE · Cap: $32.19B
NMR
Nomura Holdings Inc ADR
$8.41
-2.77%
FINANCIAL SERVICES · Cap: $25.46B
Smart Verdict
WallStSmart Research — data-driven comparison
Nomura Holdings Inc ADR generates 1116% more annual revenue ($2.17T vs $178.33B). NMR leads profitability with a 16.7% profit margin vs -3.6%. NMR appears more attractively valued with a PEG of 0.82. NMR earns a higher WallStSmart Score of 70/100 (B-).
CNC
Buy57
out of 100
Grade: C
NMR
Strong Buy70
out of 100
Grade: B-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+85.0%
Fair Value
$268.78
Current Price
$62.33
$206.45 discount
Intrinsic value data unavailable for NMR.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Generating 3.4B in free cash flow
Attractively priced relative to earnings
Reasonable price relative to book value
Growing faster than its price suggests
Revenue surging 27.5% year-over-year
Areas to Watch
ROE of -30.1% — below average capital efficiency
Currently unprofitable
4.5% earnings growth
Negative free cash flow — burning cash
Distress zone — elevated risk
Elevated debt levels
Comparative Analysis Report
WallStSmart ResearchBull Case : CNC
The strongest argument for CNC centers on Price/Book, Free Cash Flow. PEG of 1.25 suggests the stock is reasonably priced for its growth.
Bull Case : NMR
The strongest argument for NMR centers on P/E Ratio, Price/Book, PEG Ratio. Profitability is solid with margins at 16.7% and operating margin at 18.7%. Revenue growth of 27.5% demonstrates continued momentum.
Bear Case : CNC
The primary concerns for CNC are Return on Equity, Profit Margin.
Bear Case : NMR
The primary concerns for NMR are EPS Growth, Free Cash Flow, Altman Z-Score. Debt-to-equity of 4.67 is elevated, increasing financial risk.
Key Dynamics to Monitor
CNC profiles as a turnaround stock while NMR is a growth play — different risk/reward profiles.
CNC carries more volatility with a beta of 1.09 — expect wider price swings.
NMR is growing revenue faster at 27.5% — sustainability is the question.
CNC generates stronger free cash flow (3.4B), providing more financial flexibility.
Bottom Line
NMR scores higher overall (70/100 vs 57/100), backed by strong 16.7% margins and 27.5% revenue growth. CNC offers better value entry with a 85.0% margin of safety. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Centene Corp
HEALTHCARE · HEALTHCARE PLANS · USA
Centene Corporation is a large publicly traded company and a multi-line managed care enterprise that serves as a major intermediary for both government-sponsored and privately insured health care programs. It is a healthcare insurer that focuses on managed care for uninsured, underinsured, and low-income individuals.
Nomura Holdings Inc ADR
FINANCIAL SERVICES · CAPITAL MARKETS · USA
Nomura Holdings, Inc. provides various financial services to individuals, corporations, financial institutions, governments, and government agencies worldwide. The company is headquartered in Tokyo, Japan.
Compare with Other HEALTHCARE PLANS Stocks
Want to dig deeper into these stocks?